Diphenylhydantoin antibody
Ref. 3D-20-RDIWDPH
| 1ml | 175.00 € |
Product Information
The Diphenylhydantoin antibody is a powerful monoclonal antibody that targets multidrug resistance in cancer cells. It specifically binds to diphenylhydantoin, a commonly used antiepileptic drug, and blocks its efflux from cancer cells. This antibody has shown promising results in increasing the efficacy of chemotherapy by reversing drug resistance.
In addition to its role in multidrug resistance, the Diphenylhydantoin antibody has been found to have other therapeutic applications. It inhibits the activity of adrenomedullin, a peptide hormone involved in angiogenesis, and reduces microvessel density in tumors. Furthermore, this antibody interacts with glucagon and tumor necrosis factor-alpha (TNF-α), two key players in inflammation and immune response.
The Diphenylhydantoin antibody is highly specific and exhibits minimal cross-reactivity with other compounds. It is available as a polyclonal antibody, ensuring high affinity and specificity for its target. Researchers
Chemical properties
Technical inquiry about: 3D-20-RDIWDPH Diphenylhydantoin antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
